Pre-market hot trades in US stocks: Hecla Mining up 7.93% in pre-market; AXIL Brands down 7.81% in pre-market

Pre-market Hot Trades in US Stocks Hecla Mining is up 7.93% in pre-market trading. Based on recent key news: On January 10, Hecla Mining, as a top silver producer in the US and Canada, has outperformed silver prices, but its stock valuation is relatively high. Analysts believe that the continued rise in silver prices may require an increase in earnings expectations and target prices, but silver prices appear overstretched relative to gold and other commodities, which may be difficult to maintain. Source: Barron's On January 9, MarketBeat tracked recommendations from top Wall Street analysts, and Hecla Mining was not included in the recommended list, with a current rating of hold. Analysts believe there are five stocks with greater investment value. Source: MarketBeat The volatility of silver prices affects the performance of mining stocks, and risks need to be monitored. AXIL Brands is down 7.81% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Top Gainers in Pre-market US Stocks Envirotech Vehicles is up 92.66% in pre-market trading. There is no significant news recently; the trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news Ping An Biomedical is up 47.85% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Intelligent Bio Solutions is up 44.87% in pre-market trading. Based on recent key news: On January 8, Intelligent Bio Solutions released the latest company information through the EDGAR system, driving the stock price up. This information, operated by the US Securities and Exchange Commission, shows the latest developments in the company's financial and operational aspects, enhancing market confidence and leading to a significant pre-market price increase. On January 9, analysts rated Intelligent Bio Solutions as hold, with a target price of $11. Although the company's revenue has improved, the rating remains neutral due to operational losses and cash consumption. The technical aspect shows the stock price above key moving averages, supporting the price increase. Recent company developments are mixed, with financing and expected manufacturing cost savings offset by compliance-driven reverse stock splits. Despite the company's market value being only $10.27 million, trading volume is active, and technical signals indicate selling, but the stock price still shows an upward trend. The volatility in the US stock market has intensified, and risks need to be monitored